- Home
- ADVM vs LWAY Comparison
ADVM vs LWAY Comparison
Compare ADVM & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- LWAY
- Stock Information
- Founded
- ADVM 2006
- LWAY 1986
- Country
- ADVM United States
- LWAY United States
- Employees
- ADVM N/A
- LWAY N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- LWAY Packaged Foods
- Sector
- ADVM Health Care
- LWAY Consumer Staples
- Exchange
- ADVM Nasdaq
- LWAY Nasdaq
- Market Cap
- ADVM 66.3M
- LWAY 464.0M
- IPO Year
- ADVM 2014
- LWAY 1987
- Fundamental
- Price
- ADVM $3.07
- LWAY $33.72
- Analyst Decision
- ADVM Strong Buy
- LWAY Buy
- Analyst Count
- ADVM 4
- LWAY 2
- Target Price
- ADVM $19.75
- LWAY $33.00
- AVG Volume (30 Days)
- ADVM 78.2K
- LWAY 68.6K
- Earning Date
- ADVM 11-03-2025
- LWAY 11-13-2025
- Dividend Yield
- ADVM N/A
- LWAY N/A
- EPS Growth
- ADVM N/A
- LWAY N/A
- EPS
- ADVM N/A
- LWAY 0.70
- Revenue
- ADVM $1,000,000.00
- LWAY $193,021,000.00
- Revenue This Year
- ADVM $1,836.70
- LWAY $14.66
- Revenue Next Year
- ADVM N/A
- LWAY $13.81
- P/E Ratio
- ADVM N/A
- LWAY $47.50
- Revenue Growth
- ADVM N/A
- LWAY 9.19
- 52 Week Low
- ADVM $1.78
- LWAY $19.50
- 52 Week High
- ADVM $8.56
- LWAY $33.61
- Technical
- Relative Strength Index (RSI)
- ADVM 51.69
- LWAY 73.13
- Support Level
- ADVM $2.95
- LWAY $28.55
- Resistance Level
- ADVM $3.59
- LWAY $32.85
- Average True Range (ATR)
- ADVM 0.22
- LWAY 1.19
- MACD
- ADVM -0.03
- LWAY 0.13
- Stochastic Oscillator
- ADVM 21.21
- LWAY 98.48
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.